[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Journey Medical Corp (DERM)

Journey Medical Corp (DERM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Journey Medical Corp 9237 E VIA DE VENTURA BLVD. SUITE 105 SCOTTSDALE AZ 85258 USA

www.jmcderm.com Employees: 58 P: 480-434-6670

Sector:

Medical

Description:

Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.

Key Statistics

Overview:

Market Capitalization, $K 140,208
Enterprise Value, $K 141,398
Shares Outstanding, K 27,331
Float, K 23,223
% Float 84.97%
Short Interest, K 3,457
Short Float 12.65%
Days to Cover 7.25
Short Volume Ratio 0.67
% of Insider Shareholders 15.03%
% of Institutional Shareholders 7.25%

Financials:

Annual Sales, $ 61,860 K
Annual Net Income, $ -11,430 K
Last Quarter Sales, $ 16,080 K
Last Quarter Net Income, $ -1,250 K
EBIT, $ -3,910 K
EBITDA, $ 900 K

Growth:

1-Year Return -32.87%
3-Year Return 196.53%
5-Year Return 0.00%
5-Year Revenue Growth 38.92%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 03/25/26
Next Earnings Date 05/13/26 [--]
Earnings Per Share ttm -0.47
EPS Growth vs. Prev Qtr 55.56%
EPS Growth vs. Prev Year -150.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

DERM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 26.53
Price/Earnings to Growth N/A
Return-on-Equity % -46.40%
Return-on-Assets % -13.22%
Profit Margin % -18.48%
Debt/Equity 0.79
Price/Sales 2.23
Price/Cash Flow N/A
Price/Book 5.26
Book Value/Share 0.96
Interest Coverage -2.07
60-Month Beta 1.03
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.